Navigation Links
Trans Ionics Announces New Service - Custom Separation Synthesis (CSS)(TM)
Date:8/26/2009

THE WOODLANDS, Texas, Aug. 26 /PRNewswire/ -- Trans Ionics Corporation announced today that it will immediately begin providing a service called Custom Separation Synthesis(TM) to customers primarily in the petroleum and chemical industries, who currently have difficult separation problems for which they would like more economically viable solutions. "The goal of CSS is to provide customers with alternative separation schemes that are lower in capital and operating costs than separation systems currently available in the marketplace," says Dr. Robert Schucker, recipient of 47 U.S. and international patents for unique separation solutions, and CEO of Trans Ionics, which he founded on his retirement from a 23 year career with ExxonMobil.

The advent of CSS builds on the successful creation by Trans Ionics of five revolutionary separation processes in the past ten years. "The difference with CSS is that the customer will own the technology from the outset. Based on the customer's description of the need, Trans Ionics will develop the separation concept (including a limited patent and literature search), carry out experiments to confirm the viability of the process, generate initial supporting data and put together a process design with heat and material balances using state-of-the-art process simulation software. The advantage to the customer is that they get a fresh viewpoint on solutions to their separation problems, based on the wealth of experience of Trans Ionics' personnel in separations and will be involved in the process from the beginning," continued Dr. Schucker.

Trans Ionics is a leader in the development of advanced separation technologies for the petroleum, petrochemical, environmental, medical and power generation sectors. Located in The Woodlands, TX just north of Houston, the Company has created energy-saving processes for (1) the separation of pure oxygen from air using ion transport membranes based on a unique material licensed from the University of Houston (SeprOx(TM)), (2) desulfurization of a wide range of petroleum streams (TransFining(TM)), (3) recovery of olefins (like propylene and ethylene) from mixed gas streams (MMEO(TM)), (4) recovery of benzene and other high valued aromatics from chemical plant streams (BenzSep(TM)) and (5) recovery of ethanol and/or butanol from fermentation liquids (ESep(TM)).

Trans Ionics has been awarded 8 patents and has 9 additional applications pending for its separation technologies. MMEO and BenzSep are currently available for sale to interested parties.


'/>"/>
SOURCE Trans Ionics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Nation's Leading Provider of Medical Transcription Services to Physician Practices, MxSecure, Inc., Named to Inc. 5000 Fastest Growing Private Companies in America
2. New Study Reveals VASER(R) Lipo to be the New Standard of Care for Body Contouring and Fat Transfer Procedures
3. Double Recipient Twitters Transplant Olympic Training and Tackles Nursing School
4. Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
5. Emdeon and BroMenn Healthcare System Take the Lead on Consumer Price Transparency
6. Still holding their breath: Mortality on lung transplant wait list remains high for some
7. Dallas Physician Elected to Lead International Organ Transplant Society
8. Single Kidney Transplant From Young, Deceased Donors Works Well
9. Night home hemodialysis shown to be as good as transplant in treating kidney failure
10. National Practice Transition Network Attracting National Attention as the Country's First Membership-Based, Commission-Free Dental Practice Transition Company
11. Confronting Health Disparities Among Lesbian, Gay, Bisexual and Transgender Youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... announced it has been featured in SuperbCrew magazine, a leading online tech news ... world. This interview, now featured on SuperbCrew.com, explores the state of enterprise mobility ...
(Date:12/5/2016)... ... December 05, 2016 , ... Researchers at Johns Hopkins All Children’s ... of young athletes. Over the course of three years, researchers will study concussions and ... The mouth guards, equipped with special sensors, will track the location and force of ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy Awareness,” which can be ... sparks a conversation about epilepsy, bearing down on the social stigma and lack ... diagnosed with epilepsy within their lifetime. With such a large percentage of people ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... gender, and geographic lines. The goal of Castlewood Treatment Centers has always been ... accessible to as many people as possible. In that spirit, Castlewood has ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Cornerstone ... company, today presented data from two Phase I ... sessions at the 58th annual meeting of the ... San Diego, California . The two datasets ... with acute myeloid leukemia (AML) and T-cell non-Hodgkin,s ...
(Date:12/5/2016)... 5, 2016  Pennsylvania Physician General Dr. Rachel ... Gary Tennis today filled prescriptions for naloxone, ... in York to demonstrate how ... Levine as a prescription to acquire naloxone at any ... to remember that any Pennsylvanian can walk up to ...
Breaking Medicine Technology: